← Back to Clinical Trials
Recruiting NCT07021508

NCT07021508 Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07021508
Status Recruiting
Phase
Sponsor First Affiliated Hospital of Zhejiang University
Condition Bipolar Depression
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2025-05-20
Primary Completion 2026-05

Trial Parameters

Condition Bipolar Depression
Sponsor First Affiliated Hospital of Zhejiang University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 160
Sex ALL
Min Age 18 Years
Max Age 45 Years
Start Date 2025-05-20
Completion 2026-05
Interventions
Temporal Interference StimulationSham Temporal Interference Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aim of this study was to explore the efficacy and safety of temporal interference stimulation to improve bipolar depression, as well as to explore the corresponding neuroimaging mechanisms using magnetic resonance and electroencephalogram to provide novel intervention protocols and objective indicators of efficacy prediction for depressive episodes in bipolar disorder.

Eligibility Criteria

Inclusion Criteria: * right-handed, and have completed nine years of compulsory education; * Meet the diagnostic criteria for bipolar depression in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); * ≥18 points on the Hamilton Depression Inventory (HAMD- 17); * ≤8 points on the Young's Mania Rating Scale (YMRS); * Subjects who have not been treated with psychiatric medication, or those who have been treated with medication are required to undergo medication washout within 2 weeks before randomization; * Subjects/legal guardians are willing to cooperate with the treatment and sign an informed consent form after they have fully understood the Temporal Interference Stimulation (TI). Exclusion Criteria: * Contraindications to magnetic resonance scanning (MRI) or time-interference stimulation (TI), such as the presence of metallic or electronic devices in the body (intracranial metallic foreign bodies, cochlear implants, pacemakers and stents, and other metal

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology